Reference [1] Tan Q, Akindehin S E, Orsso C E, et al
Overweight and obesity in youths (519 years) climbed from roughly 8% in 1990 to about 20% by 2022, affecting approximately 160 million young people globally
Although weight loss with Wegovy varies from person to person and can be influenced by several factors, there are some general timeline expectations for weight loss based on clinical studies and patient reporting
Semaglutide injection should appear clear and colorless to slightly pale yellow when properly manufactured and stored
Built-in exit strategy
Addressing these gaps will require interdisciplinary approaches, including the development of advanced drug delivery systems to enhance bioavailability, comprehensive clinical studies to validate the therapeutic effects, and the use of omics technologies to elucidate multi-target actions and off-target effects